QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=DE304EC9CDF11B7124964268841F1366;jsessionid=C57F5F3FC8F419FF7AD96B2ECA778D7B;jsessionid=F3AC39E02C03B8FC1C05608D4F4294FC;jsessionid=C21833EF20526481598A7874BCFEAA09;jsessionid=05A6E1BEE0C7D47FCE146552D25BA8EF;jsessionid=F8047CDDF18B95B155B0B40443A50CDE;jsessionid=30E44F82BC2D39044C4125B31500095C (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=DE304EC9CDF11B7124964268841F1366;jsessionid=C57F5F3FC8F419FF7AD96B2ECA778D7B;jsessionid=F3AC39E02C03B8FC1C05608D4F4294FC;jsessionid=C21833EF20526481598A7874BCFEAA09;jsessionid=05A6E1BEE0C7D47FCE146552D25BA8EF;jsessionid=F8047CDDF18B95B155B0B40443A50CDE;jsessionid=30E44F82BC2D39044C4125B31500095C